Group 1: Company Performance and Strategy - The company is focused on enhancing R&D capabilities and flexible production to meet diverse consumer demands, aiming to improve brand awareness and market share [2][3] - The company does not plan to establish its own cosmetics brand but will increase business expansion efforts and improve production capacity utilization in Huzhou [3][4] - The decline in revenue is attributed to lower market demand, low capacity utilization, and increased fixed costs, with a commitment to leverage strengths in product development and quality management to improve profitability in 2025 [3][4] Group 2: Market Outlook and Industry Trends - The long-term outlook for the cosmetics industry remains positive, with stable economic growth and rising national income levels, indicating significant market potential [3][4] - In 2024, the retail sales of cosmetics in China reached 435.65 billion yuan, showing a slight decline of 1.1%, reflecting short-term challenges in the industry [4] - The company is optimistic about future growth opportunities and aims to expand its customer base and business scale in 2025 [4]

Group 1 - Geely Auto proposed to privatize Zeekr with an offer of $2.57 per share, representing a 13.6% premium over the last trading price [1] - The offer also includes a premium of 20.0% over the volume-weighted average price of the last 30 trading days [1] - Geely currently holds approximately 65.7% of Zeekr's issued share capital [1] Group 2 - Sun Group announced the U.S. Department of Commerce has revoked its investigation into steel wheels made in Vietnam using Chinese components [2] - The revocation is expected to positively impact the company's export orders and future overseas business layout [2] Group 3 - Qingdao Beer plans to acquire 100% equity of Jimo Yellow Wine for a total consideration of RMB 665 million [3] - The acquisition aims to enhance industry synergy, competitiveness, and expand product lines and market channels [3] Group 4 - BeiGene reported a net loss of 94.503 million yuan in Q1 2025, a reduction in loss compared to the previous year [4] - The company achieved total revenue of 8.048 billion yuan, a year-on-year increase of 50.2%, driven by sales growth of its self-developed products [4] Group 5 - Daqin Railway reported a 0.99% year-on-year increase in cargo transportation volume for April [5] - Shaanxi Coal's self-produced coal sales reached 13.1033 million tons in April, up 0.76% year-on-year [5] Group 6 - Shennong Group sold 227,300 pigs in April, marking a 32.85% year-on-year increase [6] - Poly Developments reported a 25.44% year-on-year decrease in contracted sales amounting to 24.622 billion yuan in April [6] Group 7 - Hainan Development plans to acquire 51% equity of Wangying Technology [7] - Huafeng Measurement Control's shareholders plan to transfer 2.9% of shares at an initial price of 121.42 yuan per share [7] Group 8 - Various companies reported significant stock price fluctuations, with Changshan Pharmaceutical's injection not yet on the market and facing regulatory uncertainties [8] - The company is in the professional review stage for its diabetes treatment application [8]

国投证券股份有限公司 关于嘉亨家化股份有限公司 首次公开发行股票并在创业板上市 持续督导保荐总结报告书 经中国证券监督管理委员会证监许可[2021]488 号文核准，嘉亨家化股份有 限公司（以下简称"嘉亨家化"、"上市公司"或"公司"）于 2021 年 3 月向社会 公众公开发行人民币普通股（A 股）2,520.00 万股，并于 2021 年 3 月 24 日在深 圳证券交易所上市。 国投证券股份有限公司（以下简称"国投证券"或"保荐机构"）作为嘉亨家化 首次公开发行股票的保荐机构，持续督导职责期限至 2024 年 12 月 31 日。目前， 持续督导期限已满，现根据《证券发行上市保荐业务管理办法》等相关规定，出 具本持续督导保荐总结报告书。 一、保荐机构及保荐代表人承诺 1、保荐总结报告书和证明文件及其相关资料的内容不存在虚假记载、误导 性陈述或重大遗漏，保荐机构及保荐代表人对其真实性、准确性、完整性承担法 律责任。 2、本保荐机构及本人自愿接受中国证监会对保荐总结报告书相关事项进行 的任何质询和调查。 3、本保荐机构及本人自愿接受中国证监会按照《证券发行上市保荐业务管 理办法》的有关规定采取的监管措施。 ...

国投证券股份有限公司 关于嘉亨家化股份有限公司 2024 年度持续督导跟踪报告 | 保荐机构名称：国投证券股份有限公司 | 被保荐公司简称：嘉亨家化（300955） | | --- | --- | | 保荐代表人姓名：樊长江 | 联系电话：0755-81682186 | | 保荐代表人姓名：余中华 | 联系电话：0755-81682186 | 一、保荐工作概述 | 项 目 | 工作内容 | | --- | --- | | 1．公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 不适用 | | 2．督导公司建立健全并有效执行规章制度的情 | | | 况 | | | （1）是否督导公司建立健全规章制度（包括但 | | | 不限于防止关联方占用公司资源的制度、募集 | 是 | | 资金管理制度、内控制度、内部审计制度、关 | | | 联交易制度） | | | （2）公司是否有效执行相关规章制度 | 是 | | 3．募集资金监督情况 | | | （1）查询公司募集资金专户次数 | 不适用，公司募集资金于 2023 年度已使用 | | | 完 ...

证券代码：300955 证券简称：嘉亨家化 公告编号：2025-019 嘉亨家化股份有限公司 关于举办 2024 年度暨 2025 年第一季度 网上业绩说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 为充分尊重投资者、提升交流的针对性，现就公司 2024 年度暨 2025 年第一 季度业绩说明会提前向投资者公开征集问题，广泛听取投资者的意见和建议。投 资者可于 2025 年 5 月 9 日（星期五）17:00 前访问（https://ir.p5w.net/zj/）或扫描 下方二维码，进入问题征集专题页面。公司将在 2024 年度暨 2025 年第一季度业 绩说明会上对投资者普遍关注的问题在信息披露允许的范围内进行回答。欢迎广 1 大投资者积极参与本次网上说明会！ （问题征集专题页面二维码） 特此公告。 嘉亨家化股份有限公司 嘉亨家化股份有限公司（以下简称"公司"）已于 2025 年 4 月 23 日在巨潮资 讯网（www.cninfo.com.cn）披露了《2024 年年度报告》《2024 年年度报告摘要》， 于 2025 年 4 月 29 日在 ...

Financial Performance - The company reported a significant decline in basic earnings per share, dropping to -0.2000 yuan in Q1 2025 from -0.0300 yuan in Q1 2024, representing a decrease of 566.67% [1] - Net profit for Q1 2025 was -0.2 billion yuan, compared to -0.03 billion yuan in Q1 2024, indicating a substantial loss [1] - The return on equity (ROE) fell to -2.15% in Q1 2025 from -0.29% in Q1 2024, reflecting a decline of 641.38% [1] - Operating revenue increased to 2.19 billion yuan in Q1 2025, up 7.88% from 2.03 billion yuan in Q1 2024 [1] Shareholder Information - The top ten unrestricted shareholders collectively hold 24.2534 million shares, accounting for 41.21% of the circulating shares, with a decrease of 467,500 shares compared to the previous period [2] - The largest shareholder, Zeng Bensheng, holds 13.9846 million shares, representing 23.76% of the total share capital, with no change in holdings [2] - Shanghai Huiying Investment Partnership holds 3.0721 million shares, which is 5.22% of the total, showing a decrease of 46.75 thousand shares [2] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [3]

经审议，公司监事会认为，公司董事会编制和审议《2025 年第一季度报告》 的程序符合法律法规和中国证监会的规定，报告内容真实、准确、完整地反映了 公司 2025 年第一季度的经营成果和财务状况，不存在任何虚假记载、误导性陈 述或者重大遗漏。 嘉亨家化股份有限公司 第三届监事会第三次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 嘉亨家化股份有限公司（以下简称"公司"）第三届监事会第三次会议于 2025 年 4 月 28 日在公司及全资子公司会议室以现场与通讯相结合的方式召开，会议 通知及材料于 2025 年 4 月 25 日以电子邮件、电话及微信等方式送达全体监事。 本次会议由公司监事会主席吴丽萍女士主持，会议应到监事 3 名，实到监事 3 名。公司董事会秘书列席了本次会议。本次会议的召集、召开符合《中华人民共 和国公司法》《公司章程》及其他法律法规的相关规定。 二、监事会会议审议情况 审议通过了《关于公司 2025 年第一季度报告的议案》 证券代码：300955 证券简称：嘉亨家化 公告编号：2025-018 2 具体内 ...

嘉亨家化股份有限公司（以下简称"公司"）第三届董事会第三次会议于 2025 年 4 月 28 日在公司及全资子公司会议室以现场与通讯相结合的方式召开，会议 通知及材料于 2025 年 4 月 25 日以电子邮件、电话及微信等方式送达全体董事、 监事及高级管理人员。本次会议由公司董事长曾焕彬先生主持，会议应到董事 7 名，实到董事 7 名（其中独立董事吴锦凤女士、李磊先生、王清木先生以通讯方 式出席）。公司监事及高级管理人员列席了本次会议。本次会议的召集、召开符 合《中华人民共和国公司法》《公司章程》及其他法律法规的相关规定。 二、董事会会议审议情况 审议通过了《关于公司 2025 年第一季度报告的议案》 证券代码：300955 证券简称：嘉亨家化 公告编号：2025-017 嘉亨家化股份有限公司 第三届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1、公司第三届董事会第三次会议决议； 2、公司第三届审计委员会第四次会议决议。 1 特此公告。 嘉亨家化股份有限公司 经审议，董事会认为：《2025 年第一季度报告 ...

Financial Performance - The company's revenue for Q1 2025 was ¥218,555,927.27, representing a 7.46% increase compared to ¥203,383,105.98 in the same period last year[4]. - The net loss attributable to shareholders was ¥19,923,540.72, a significant increase of 584.24% from a loss of ¥2,911,790.81 in Q1 2024[4]. - The company's basic and diluted earnings per share were both -¥0.20, reflecting a decrease of 566.67% from -¥0.03 in the same period last year[4]. - The total comprehensive income for the current period is a loss of ¥19,924,019.61, compared to a loss of ¥2,911,029.35 in the previous period, highlighting a worsening financial position[22]. Cash Flow - The net cash flow from operating activities increased by 21.41% to ¥18,052,299.64, up from ¥14,868,363.95 in the previous year[4]. - The net cash flow from investing activities improved by 74.30%, decreasing to -¥30,321,962.44 from -¥117,994,232.40 in Q1 2024[11]. - The company received cash from operating activities totaling ¥247,461,540.98, down from ¥271,840,733.08 in the previous period, indicating a decline in cash inflows from operations[24]. Assets and Liabilities - The total assets at the end of Q1 2025 were ¥1,824,905,945.11, a 1.15% increase from ¥1,804,215,578.50 at the end of the previous year[4]. - Total liabilities rose to ¥909,486,112.37, compared to ¥868,871,726.15 in the previous period, marking an increase of 4.6%[18]. - The company's total equity decreased to ¥915,419,832.74 from ¥935,343,852.35, a decline of 2.1%[18]. - Cash and cash equivalents at the end of the period amounted to ¥180,542,335.37, up from ¥144,630,106.90 at the beginning of the period, reflecting a growth of 24.8%[17]. Operating Costs and Income - Total operating revenue for the current period reached ¥218,555,927.27, an increase of 7.3% compared to ¥203,383,105.98 in the previous period[20]. - Total operating costs increased to ¥242,985,812.68 from ¥212,280,018.54, reflecting a rise of about 14.5%[21]. - The company reported a significant increase in other income by 47.63% to ¥819,876.65, primarily due to increased government subsidies[10]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 7,535[12]. - The company reported a decrease in undistributed profits to ¥200,406,891.92 from ¥220,330,432.64, a decline of 9.0%[18]. Financial Expenses - Financial expenses rose by 161.24% to ¥5,085,246.99 due to increased bank loan scales and corresponding interest expenses[9]. - The company incurred financial expenses of ¥5,085,246.99, significantly higher than ¥1,946,552.13 in the previous period, indicating increased borrowing costs[21]. Inventory and Receivables - Accounts receivable decreased to ¥240,424,039.39 from ¥252,985,863.71, a reduction of 5.0%[17]. - Inventory increased to ¥166,035,598.28 from ¥158,455,767.98, reflecting a growth of 4.4%[17]. Other Information - The company has not disclosed any new product developments or market expansion strategies in the current report[15].

Core Viewpoint - 嘉亨家化 reported its worst financial results since going public, with significant declines in revenue and net profit due to weak demand in the domestic personal care market [1][2] Financial Performance - In 2024, 嘉亨家化 achieved revenue of 9.23 billion yuan, a year-on-year decrease of 9.13% [1][2] - The net profit attributable to shareholders was a loss of 23.7 million yuan, down 159.00% year-on-year [1][2] - The company's revenue and net profit have declined for three consecutive years, with 2020-2024 revenues of 9.69 billion, 11.61 billion, 10.52 billion, 10.16 billion, and 9.23 billion yuan, respectively [2][4] Market Demand and Client Dependency - The decline in performance is attributed to lower-than-expected demand in the skincare and beauty market, affecting major clients [4] - 嘉亨家化's revenue is heavily reliant on its top five clients, which accounted for 67.65% of total revenue in 2024 [4][5] - Major clients include Johnson & Johnson, Beitaini, and Shanghai Jahwa, with the largest client contributing 18.19% of total revenue [5] Product Sales Decline - The sales of cosmetics were 4.55 billion yuan, down 15.63% year-on-year, while plastic packaging container sales were 3.8 billion yuan, down 2.82% [1][5][6] Production Capacity Utilization - The actual capacity utilization for cosmetics was only 32.76%, and for household care products, it was 26.25% [7][8] - Low capacity utilization has led to increased fixed costs, negatively impacting the company's gross profit margin, which decreased by 4.55% [7][9] Asset Management - 嘉亨家化's fixed assets increased by 63% to 1.04 billion yuan due to the completion of construction projects [8] - The total asset turnover ratio has declined over the past three years, indicating weakening asset management efficiency [9]